Education
About Us
Working with TipRanks
Follow Us
Aldeyra Therapeutics (DE:137)
FRANKFURT:137
Aldeyra Therapeutics (137) Ownership Overview
19.01% Insiders
11.23% Mutual Funds
26.63% Other Institutional Investors
8.81% ETFs
34.32% Public Companies and Individual Investors
The ownership structure of Aldeyra Therapeutics (DE:137) stock is a mix of institutional, retail, and individual investors. Approximately 46.67% of the company’s stock is owned by Institutional Investors, 19.01% is owned by Insiders, and 34.32% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Oct 21, 2024 | Nancy Miller Rich Director | xxxxxxxxxxxxx | $10447 |
| Aug 14, 2024 | xxxxxxxxxxxxx | $75874 | |
| Apr 08, 2024 | Perceptive Advisors Llc Director, >10% Owner | xxxxxxxxxxxxx | $833867 |
| Apr 03, 2024 | Perceptive Advisors Llc Director, >10% Owner | xxxxxxxxxxxxx | $1934505 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $5738500 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,275,851 | Institution | 15.58% | 58,456,413 | |
| 9,275,851 | Insider | 15.58% | 58,456,413 | |
| 2,859,213 | Institution | 4.80% | 18,018,760 | |
| 2,456,281 | Institution | 4.12% | 15,479,483 | |
| 2,008,531 | Institution | 3.37% | 12,657,762 | |
| 1,471,298 | Insider | 2.47% | 9,272,120 | |
| 1,150,000 | Institution | 1.93% | 7,247,300 | |
| 680,004 | Institution | 1.14% | 4,285,385 | |
| 568,298 | Institution | 0.95% | 3,581,414 | |
| 547,959 | Institution | 0.92% | 3,453,238 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,456,281 | Institution | 4.12% | 15,479,483 | |
| 680,004 | Institution | 1.14% | 4,285,385 | |
| 568,298 | Institution | 0.95% | 3,581,414 | |
| 547,959 | Institution | 0.92% | 3,453,238 | |
| 449,895 | Institution | 0.76% | 2,835,238 | |
| 333,200 | Institution | 0.56% | 2,099,826 | |
| 272,169 | Institution | 0.46% | 1,715,209 | |
| 222,232 | Institution | 0.37% | 1,400,506 | |
| 206,748 | Institution | 0.35% | 1,302,926 | |
| 145,603 | Institution | 0.24% | 917,590 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Aldeyra Therapeutics (DE:137)?
According to the latest TipRanks data, approximately 26.63% of the company's stock is held by institutional investors, 19.01% is held by insiders, and 34.32% is held by retail investors.
What percentage of Aldeyra Therapeutics (DE:137) stock is held by institutional investors?
According to the latest TipRanks data, approximately 26.63% of Aldeyra Therapeutics (DE:137) stock is held by institutional investors.
What percentage of Aldeyra Therapeutics (DE:137) stock is held by retail investors?
According to the latest TipRanks data, approximately 34.32% of Aldeyra Therapeutics (DE:137) stock is held by retail investors.
Who owns the most shares of Aldeyra Therapeutics (DE:137)?
Joseph Edelman owns the most shares of Aldeyra Therapeutics (DE:137).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.